Atlas Trials

Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma

Clinical trial NCT05024539 · UNKNOWN

Trial details

NCT number
NCT05024539
Sponsor
Shujun Yang
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2021-06-20
Primary completion
2022-11-21
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.